<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02629614</url>
  </required_header>
  <id_info>
    <org_study_id>ET-03</org_study_id>
    <nct_id>NCT02629614</nct_id>
  </id_info>
  <brief_title>Cala ONE Device for Essential Tremor</brief_title>
  <official_title>Multicenter Study of Safety and Effectiveness of Cala ONE Device for Essential Tremor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cala Health, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cala Health, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the safety and effectiveness of the Cala ONE device to aid in the
      symptomatic relief of hand tremors in adult essential tremor subjects. This study is a
      prospective, randomized, double-blinded, sham-controlled study.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Actual">November 2016</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in TETRAS spiral rating after stimulation</measure>
    <time_frame>Immediately before and after 40 minute stimulation session</time_frame>
    <description>The primary effectiveness variable is the change in tremor severity immediately after the stimulation session compared to baseline (immediately prior to stimulation) as measured using the TETRAS Archimedes spiral task (assessed by 3 blinded raters).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in TETRAS spiral rating during stimulation</measure>
    <time_frame>Immediately before and 30 minutes into stimulation session</time_frame>
    <description>An additional analysis variable is the change in tremor severity during the stimulation session (30 minutes into stimulation session) compared to baseline (immediately prior to stimulation) as measured using the TETRAS Archimedes spiral task (assessed by 3 blinded raters).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-report improvement</measure>
    <time_frame>Immediately before and after 40 minute stimulation session</time_frame>
    <description>The proportion of subjects in the treatment group indicating improvement on the CGI-I Scale will be compared to the sham group</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Change in kinetic tremor</measure>
    <time_frame>Immediately before and after 40 minute stimulation session</time_frame>
    <description>The change in tremor severity on the kinetic tremor task as assessed by an investigator using the TETRAS rating scale.</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in kinetic tremor</measure>
    <time_frame>Immediately before and 30 minutes into stimulation session</time_frame>
    <description>The change in tremor severity on the kinetic tremor task as assessed by an investigator using the TETRAS rating scale.</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in lateral &quot;wing beating&quot; postural tremor</measure>
    <time_frame>Immediately before and after 40 minute stimulation session</time_frame>
    <description>The change in tremor severity in the lateral &quot;wing beating&quot; postural tremor task as assessed by an investigator using the TETRAS rating scale.</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in lateral &quot;wing beating&quot; postural tremor</measure>
    <time_frame>Immediately before and 30 minutes into stimulation session</time_frame>
    <description>The change in tremor severity in the lateral &quot;wing beating&quot; postural tremor task as assessed by an investigator using the TETRAS rating scale.</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in forward outstretched postural tremor</measure>
    <time_frame>Immediately before and after 40 minute stimulation session</time_frame>
    <description>The change in tremor severity on outstretched tremor task as assessed by an investigator using the TETRAS rating scale.</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in forward outstretched postural tremor</measure>
    <time_frame>Immediately before and 30 minutes into stimulation session</time_frame>
    <description>The change in tremor severity on outstretched tremor task as assessed by an investigator using the TETRAS rating scale.</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Bain &amp; Findley ADL: Use a spoon to drink liquid</measure>
    <time_frame>Immediately before and after 40 minute stimulation session</time_frame>
    <description>The change in tremor severity on drinking liquid with a spoon as assessed by the subject using the Bain &amp; Findey ADL rating scale</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Bain &amp; Findley ADL: Hold a cup of liquid</measure>
    <time_frame>Immediately before and after 40 minute stimulation session</time_frame>
    <description>The change in tremor severity on holding a cup of liquid as assessed by the subject using the Bain &amp; Findey ADL rating scale</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Bain &amp; Findley ADL: Pouring</measure>
    <time_frame>Immediately before and after 40 minute stimulation session</time_frame>
    <description>The change in tremor severity on pouring as assessed by the subject using the Bain &amp; Findey ADL rating scale</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Bain &amp; Findley ADL: Dialing</measure>
    <time_frame>Immediately before and after 40 minute stimulation session</time_frame>
    <description>The change in tremor severity on dialing a telephone as assessed by the subject using the Bain &amp; Findey ADL rating scale</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Bain &amp; Findley ADL: Picking up change</measure>
    <time_frame>Immediately before and after 40 minute stimulation session</time_frame>
    <description>The change in tremor severity on picking up change as assessed by the subject using the Bain &amp; Findey ADL rating scale</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Bain &amp; Findley ADL: Inserting plug into socket</measure>
    <time_frame>Immediately before and after 40 minute stimulation session</time_frame>
    <description>The change in tremor severity on inserting a plug into a socket as assessed by the subject using the Bain &amp; Findey ADL rating scale</description>
  </other_outcome>
  <other_outcome>
    <measure>Change in Bain &amp; Findley ADL: Unlocking</measure>
    <time_frame>Immediately before and after 40 minute stimulation session</time_frame>
    <description>The change in tremor severity on unlocking a lock with a key as assessed by the subject using the Bain &amp; Findey ADL rating scale</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">93</enrollment>
  <condition>Essential Tremor</condition>
  <arm_group>
    <arm_group_label>TAPS Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Temporal Afferent Patterned Stimulation (TAPS) is alternating bursts of TENS stimulation applied to the radial and median nerves of a subject's wrist using the Cala ONE device.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>0 amplitude stimulation applied to the radial and median nerves of a subject's wrist using the Cala ONE device.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cala ONE Device</intervention_name>
    <description>The Cala ONE device is a wrist-worn stimulator which applies transcutaneous electrical stimulation non-invasively to the median and radial nerves of an individual through disposable hydrogel electrodes.</description>
    <arm_group_label>TAPS Stimulation</arm_group_label>
    <arm_group_label>Sham Stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. 22 years or older

          2. A diagnosis of essential tremor as confirmed from clinical history and examination by
             a movement disorder neurologist

          3. Signed informed consent

          4. At least one hand exhibiting kinetic tremor â‰¥ 2 as assessed by the TETRAS Archimedes
             spiral task completed during the baseline evaluation, as assessed by the Investigator
             in-person.

          5. Score of 3 or above in any one of the items of the Bain &amp; Findley ADL Scale

        Exclusion Criteria:

          1. Implanted electrical medical device, such as a pacemaker, defibrillator, or deep brain
             stimulator

          2. Previous thalamotomy procedure, including Stereotactic Thalamotomy, Gamma Knife
             Radiosurgical Thalamotomy, and focused ultrasound, for the treatment of tremor

          3. Suspected or diagnosed epilepsy or other seizure disorder

          4. Pregnant

          5. Swollen, infected, inflamed areas, or skin eruptions, open wounds, or cancerous
             lesions of skin at stimulation site

          6. Peripheral neuropathy affecting the tested upper extremity

          7. Alcoholism (score of 4 or higher on DSM-5)

          8. Other possible causes of tremor, including Parkinson's disease, drug-induced, enhanced
             physiological tremor, dystonia

          9. Other neurodegenerative disease like Parkinson-plus syndromes suspected on
             neurological examination. These include: multisystem atrophy, progressive supranuclear
             palsy, dementia with Lewy bodies, and cortical basal ganglionic degeneration

         10. Changes in medication for tremor within 1 month prior to study enrollment

         11. Change in antidepressant medication within 3 months prior to study enrollment

         12. Botulinum Toxin injection for hand tremor within 6 months prior to study enrollment

         13. Current participation in any other interventional research study

         14. Previous participation in any other Cala Health interventional research study

         15. Alcohol or caffeine consumption within 12 hours of study enrollment

        Subjects already taking medications for their essential tremor will remain on their
        medications during the study with no changes in medication type or dosage levels.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lin, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Clinical Advisor</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UCSF</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Parkinson's Institute</name>
      <address>
        <city>Sunnyvale</city>
        <state>California</state>
        <zip>94085</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kansas University Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Swedish Medical Center Seattle</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 8, 2015</study_first_submitted>
  <study_first_submitted_qc>December 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 14, 2015</study_first_posted>
  <last_update_submitted>May 16, 2018</last_update_submitted>
  <last_update_submitted_qc>May 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tremor</mesh_term>
    <mesh_term>Essential Tremor</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Data will be published, but no PHI will be made available.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

